These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 15583751)

  • 1. Polymorphonuclear leukocyte and monocyte activation induced by plasma from patients with heparin-induced thrombocytopenia in whole blood.
    Khairy M; Lasne D; Amelot A; Crespin M; Rendu F; Aiach M; Bachelot-Loza C
    Thromb Haemost; 2004 Dec; 92(6):1411-9. PubMed ID: 15583751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of platelet conjugate formation with polymorphonuclear leukocytes or monocytes in whole blood.
    Izzi B; Pampuch A; Costanzo S; Vohnout B; Iacoviello L; Cerletti C; de Gaetano G
    Thromb Haemost; 2007 Dec; 98(6):1276-84. PubMed ID: 18064325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new approach in the study of the molecular and cellular events implicated in heparin-induced thrombocytopenia. Formation of leukocyte-platelet aggregates.
    Khairy M; Lasne D; Brohard-Bohn B; Aiach M; Rendu F; Bachelot-Loza C
    Thromb Haemost; 2001 Jun; 85(6):1090-6. PubMed ID: 11434690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-induced thrombocytopenia: the role of platelet activation and therapeutic implications.
    Haas S; Walenga JM; Jeske WP; Fareed J
    Semin Thromb Hemost; 1999; 25 Suppl 1():67-75. PubMed ID: 10357155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying patients at high risk of heparin-induced thrombocytopenia-associated thrombosis with a platelet activation assay using flow cytometry.
    Maeda T; Nakagawa K; Murata K; Kanaumi Y; Seguchi S; Kawamura S; Kodama M; Kawai T; Kakutani I; Ohnishi Y; Kokame K; Okazaki H; Miyata S
    Thromb Haemost; 2017 Jan; 117(1):127-138. PubMed ID: 27734072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of platelet-polymorphonuclear leukocyte interactions: new clues to the antithrombotic properties of parnaparin, a low molecular weight heparin.
    Maugeri N; de Gaetano G; Barbanti M; Donati MB; Cerletti C
    Haematologica; 2005 Jun; 90(6):833-9. PubMed ID: 15951297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of the heparin-induced thrombocytopenia syndrome.
    Warkentin TE
    Semin Thromb Hemost; 2004 Jun; 30(3):273-83. PubMed ID: 15282649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet activation, upregulation of CD11b/ CD18 expression on leukocytes and increase in circulating leukocyte-platelet aggregates in Indian women chronically exposed to biomass smoke.
    Ray MR; Mukherjee S; Roychoudhury S; Bhattacharya P; Banerjee M; Siddique S; Chakraborty S; Lahiri T
    Hum Exp Toxicol; 2006 Nov; 25(11):627-35. PubMed ID: 17211980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of platelet binding on whole blood flow cytometry assays of monocyte and neutrophil procoagulant activity.
    Barnard MR; Linden MD; Frelinger AL; Li Y; Fox ML; Furman MI; Michelson AD
    J Thromb Haemost; 2005 Nov; 3(11):2563-70. PubMed ID: 16241954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet GPIIb/IIIa antagonist, XV459, in heparin-induced thrombocytopenia.
    Mousa SA; Ahmad S
    Am J Hematol; 2007 Apr; 82(4):276-82. PubMed ID: 17039513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated Platelet-Derived and Leukocyte-Derived Circulating Microparticles and the Risk of Thrombosis in Heparin-Induced Thrombocytopenia: A Role for PF4-Bearing Microparticles?
    Campello E; Radu CM; Duner E; Lombardi AM; Spiezia L; Bendo R; Ferrari S; Simioni P; Fabris F
    Cytometry B Clin Cytom; 2018 Mar; 94(2):334-341. PubMed ID: 28052584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
    Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
    Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative use of iloprost in cardiac surgery patients diagnosed with heparin-induced thrombocytopenia-reactive antibodies or with true HIT (HIT-reactive antibodies plus thrombocytopenia): An 11-year experience.
    Palatianos G; Michalis A; Alivizatos P; Lacoumenda S; Geroulanos S; Karabinis A; Iliopoulou E; Soufla G; Kanthou C; Khoury M; Sfyrakis P; Stavridis G; Astras G; Vassili M; Antzaka C; Marathias K; Kriaras I; Tasouli A; Papadopoulos K; Katafygioti M; Matoula N; Angelidis A; Melissari E
    Am J Hematol; 2015 Jul; 90(7):608-17. PubMed ID: 25808486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parnaparin, a low-molecular-weight heparin, prevents P-selectin-dependent formation of platelet-leukocyte aggregates in human whole blood.
    Maugeri N; Di Fabio G; Barbanti M; de Gaetano G; Donati MB; Cerletti C
    Thromb Haemost; 2007 Jun; 97(6):965-73. PubMed ID: 17549299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-induced thrombocytopenia: the role of platelets genetic polymorphisms.
    Pamela S; Anna Maria L; Elena D; Giovanni M; Emanuele A; Silvia V; Carmen B; Andreas G; Fabrizio F
    Platelets; 2013; 24(5):362-8. PubMed ID: 22793995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro efficacy of platelet glycoprotein IIb/IIIa antagonist in blocking platelet function in plasma of patients with heparin-induced thrombocytopenia.
    Mak KH; Kottke-Marchant K; Brooks LM; Topol EJ
    Thromb Haemost; 1998 Dec; 80(6):989-93. PubMed ID: 9869172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers.
    Graff J; Harder S; Wahl O; Scheuermann EH; Gossmann J
    Clin Pharmacol Ther; 2005 Nov; 78(5):468-76. PubMed ID: 16321613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration.
    Kozek-Langenecker SA; Spiss CK; Michalek-Sauberer A; Felfernig M; Zimpfer M
    Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A colorimetric, metabolic dye reduction assay detects highly activated platelets: application in the diagnosis of heparin-induced thrombocytopenia.
    Prechel MM; Escalante V; Drenth AF; Walenga JM
    Platelets; 2012; 23(1):69-80. PubMed ID: 21736539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apixaban as an alternate oral anticoagulant for the management of patients with heparin-induced thrombocytopenia.
    Walenga JM; Prechel M; Hoppensteadt D; Escalante V; Chaudhry T; Jeske WP; Bakhos M
    Clin Appl Thromb Hemost; 2013 Sep; 19(5):482-7. PubMed ID: 23780399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.